New study tests how a common sedative changes brain activity during surgery
NCT ID NCT07259460
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the drug dexmedetomidine, given through a precise infusion pump, affects brain wave monitors and pain sensors in 60 adults undergoing general anesthesia with propofol and remifentanil. Researchers want to see if changes in dexmedetomidine levels alter the Patient State Index, EEG patterns, and the Analgesia Nociception Index. The goal is to improve how doctors monitor sedation and pain during surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexmedetomidine
- What this could lead to
- If successful, this could help anesthesiologists better adjust sedation and pain control during surgery, potentially improving patient safety and recovery.
- What could go wrong
- This is a small, early-phase observational study with only 60 participants. It does not test a new treatment or cure, so results may not change clinical practice directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADJUVANTS, ANESTHESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Treviso Regional Hospital
RECRUITINGTreviso, TV, 31100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.